# Moberg Pharma (Sweden)

> company in Bromma, Sweden

**Wikidata**: [Q10587142](https://www.wikidata.org/wiki/Q10587142)  
**Source**: https://4ort.xyz/entity/moberg-pharma-sweden

## Summary
Moberg Pharma is a public pharmaceutical company headquartered in Bromma, Sweden, specializing in the development and commercialization of treatments for skin diseases and oncology. Founded in 2006, it is listed on Nasdaq Stockholm under the ticker MOB and operates as an *aktiebolag* (Swedish joint-stock company).

## Key Facts
- **Founded**: 2006
- **Headquarters**: Bromma city district, Stockholm, Sweden (coordinates: 59.332829° N, 17.980106° E)
- **Legal Form**: *Aktiebolag* (Swedish public limited company)
- **Stock Exchange**: Listed on Nasdaq Stockholm AB under the ticker **MOB**
- **ISIN**: SE0020353928
- **Swedish Organization Number**: 556697-7426
- **Legal Entity Identifier (LEI)**: 549300XFXK7DVGDRP410
- **Twitter Handle**: @MobergPharma (active since May 28, 2015)
- **Website**: [mobergpharma.com](http://mobergpharma.com/)
- **Crunchbase ID**: moberg-derma
- **ROR ID**: 00kchf187
- **GRID ID**: grid.451743.0
- **OpenCorporates ID**: se/556697-7426
- **Wikidata Description**: "company in Bromma, Sweden"

## FAQs
**What does Moberg Pharma specialize in?**
Moberg Pharma focuses on developing and commercializing pharmaceutical products, particularly in dermatology (skin diseases) and oncology (cancer treatments).

**Where is Moberg Pharma headquartered?**
The company is based in Bromma, a district in Stockholm, Sweden, with precise coordinates at 59.332829° N, 17.980106° E.

**When was Moberg Pharma founded?**
Moberg Pharma was established in 2006 and has been publicly traded since its listing on Nasdaq Stockholm.

**How can I invest in Moberg Pharma?**
The company’s shares are publicly traded on Nasdaq Stockholm under the ticker symbol **MOB**, allowing investors to purchase stock through the exchange.

**What is Moberg Pharma’s legal structure?**
It operates as an *aktiebolag*, the Swedish equivalent of a public limited company, with the Swedish organization number 556697-7426.

## Why It Matters
Moberg Pharma plays a critical role in advancing treatments for dermatological conditions and oncology, addressing unmet medical needs in these therapeutic areas. As a publicly traded company, it contributes to Sweden’s biopharmaceutical sector, driving innovation and economic growth. Its presence on Nasdaq Stockholm also provides investors with opportunities to support healthcare advancements while benefiting from potential financial returns.

## Notable For
- Being a publicly listed pharmaceutical company on Nasdaq Stockholm (ticker: MOB).
- Specializing in dermatology and oncology, two high-impact medical fields.
- Operating as an *aktiebolag*, a key legal structure for Swedish businesses.
- Holding multiple global identifiers (ISIN, LEI, ROR, GRID) for regulatory and research purposes.
- Maintaining an active digital presence, including a corporate Twitter account (@MobergPharma) since 2015.

## Body

### **Company Overview and Legal Structure**
Moberg Pharma is a Swedish pharmaceutical company founded in 2006, headquartered in Bromma, Stockholm. It operates as an *aktiebolag*, a Swedish legal form equivalent to a public limited company, allowing it to issue shares to the public. The company is registered under the Swedish organization number **556697-7426** and holds a Legal Entity Identifier (LEI) of **549300XFXK7DVGDRP410**, ensuring compliance with global financial transparency standards.

### **Public Listing and Financial Identifiers**
Moberg Pharma is publicly traded on **Nasdaq Stockholm AB** under the ticker symbol **MOB**. Its International Securities Identification Number (ISIN) is **SE0020353928**, facilitating international trading and investment. The company’s stock exchange presence enables it to raise capital for research, development, and commercialization of its pharmaceutical products.

### **Corporate Identifiers and Digital Presence**
The company is recognized across multiple global databases:
- **ROR ID**: 00kchf187 (Research Organization Registry)
- **GRID ID**: grid.451743.0 (Global Research Identifier Database)
- **OpenCorporates ID**: se/556697-7426
- **Crunchbase ID**: moberg-derma
- **Google Knowledge Graph ID**: /g/11dyhwzms
- **Scilit Organization ID**: 42563

Its official website, [mobergpharma.com](http://mobergpharma.com/), serves as a primary source of corporate and investor information. The company also maintains an active Twitter account, **@MobergPharma**, which has been operational since **May 28, 2015**.

### **Geographic and Operational Details**
Moberg Pharma’s headquarters are located in **Bromma**, a district in western Stockholm, Sweden. The precise geographic coordinates of its office are **59.332829° N, 17.980106° E**. Bromma is known for its business-friendly environment and proximity to Stockholm’s life sciences hub, providing strategic advantages for pharmaceutical research and development.

### **Industry Focus and Therapeutic Areas**
The company specializes in two key medical fields:
1. **Dermatology**: Developing treatments for skin diseases, including inflammatory conditions and infections.
2. **Oncology**: Advancing therapies for cancer, targeting unmet needs in patient care.

This dual focus positions Moberg Pharma as a contributor to both dermatological and oncological innovation, addressing critical gaps in medical treatment options.

### **Regulatory and Compliance Framework**
As a publicly traded company in Sweden, Moberg Pharma adheres to stringent regulatory requirements, including financial disclosure obligations under Swedish and EU securities laws. Its listing on Nasdaq Stockholm mandates transparency in reporting, ensuring investor confidence and market integrity.

### **Historical Context and Evolution**
Since its inception in **2006**, Moberg Pharma has evolved from a startup into a publicly listed entity, reflecting its growth in the competitive pharmaceutical landscape. The company’s journey includes milestones such as its IPO, expansion into specialized therapeutic areas, and establishment of a robust corporate identity with global identifiers.

### **Related Entities and Affiliations**
Moberg Pharma is linked to several external databases and platforms, including:
- **Wikidata**: Classified as a "public company" and "business" with a single sitelink (Swedish Wikipedia).
- **Crunchbase**: Listed under the identifier "moberg-derma," providing startup and investment data.
- **Scilit**: Recognized as a research organization with ID **42563**, indicating its involvement in scientific publications.

These affiliations underscore the company’s integration into both commercial and research ecosystems, enhancing its visibility and credibility.

### **Future Outlook**
As a publicly traded pharmaceutical company, Moberg Pharma is poised to continue its focus on dermatology and oncology, leveraging its public status to fund innovation. Its strategic location in Stockholm, combined with Sweden’s strong life sciences infrastructure, positions it for sustained growth in the global healthcare market.

## References

1. GRID Release 2017-05-22
2. Global LEI Index
3. [Crunchbase](http://www.crunchbase.com/organization/moberg-derma)